Your browser doesn't support javascript.
loading
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sugiura, Isamu; Doki, Noriko; Hata, Tomoko; Cho, Ryuko; Ito, Toshiro; Suehiro, Youko; Tanaka, Masatsugu; Kako, Shinichi; Matsuda, Mitsuhiro; Yokoyama, Hisayuki; Ishikawa, Yuichi; Taniguchi, Yasuhiro; Hagihara, Maki; Ozawa, Yukiyasu; Ueda, Yasunori; Hirano, Daiki; Sakura, Toru; Tsuji, Masaaki; Kamae, Tsuyoshi; Fujita, Hiroyuki; Hiramoto, Nobuhiro; Onoda, Masahiro; Fujisawa, Shin; Hatta, Yoshihiro; Dobashi, Nobuaki; Nishiwaki, Satoshi; Atsuta, Yoshiko; Kobayashi, Yukio; Hayakawa, Fumihiko; Ohtake, Shigeki; Naoe, Tomoki; Miyazaki, Yasushi.
Afiliación
  • Sugiura I; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Doki N; Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, Japan.
  • Hata T; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Cho R; Department of Hematology, Saiseikai Narashino Hospital, Chiba, Japan.
  • Ito T; Department of Hematology, National Hospital Organization Matsumoto Medical Center, Matsumoto, Japan.
  • Suehiro Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Matsuda M; Department of Hematology, PL General Hospital, Tondabayashi, Japan.
  • Yokoyama H; Department of Hematology, Sendai Medical Center, Sendai, Japan.
  • Ishikawa Y; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Taniguchi Y; Department of Hematology and Rheumatology, Kindai University Hospital, Osakasayama, Japan.
  • Hagihara M; Department of Hematology and Clinical Immunology, Yokohama City University Hospital, Yokohama, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Hirano D; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Sakura T; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Tsuji M; Department of Hematology and Immunology, Otsu Red Cross Hospital, Otsu, Japan.
  • Kamae T; Department of Hematology, Otemae Hospital, Osaka, Japan.
  • Fujita H; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan.
  • Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Onoda M; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Fujisawa S; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Hatta Y; Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Dobashi N; Division of Clinical Oncology/Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Nishiwaki S; Department of Hematology, Nagoya University Hospital, Nagoya, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Kobayashi Y; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Hayakawa F; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Ohtake S; Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan; and.
  • Naoe T; Department of Hematology, Kanazawa University, Kanazawa, Japan.
  • Miyazaki Y; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Blood Adv ; 6(2): 624-636, 2022 01 25.
Article en En | MEDLINE | ID: mdl-34516628

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cromosoma Filadelfia / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Adult / Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cromosoma Filadelfia / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Adult / Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Japón